Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-02-25
1986-11-18
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549 27, A61K 3139
Patent
active
046236562
ABSTRACT:
3-N-methylcarbamoylthioxanthen-9-one 10,10-dioxide of formula (I) ##STR1## is an inhibitor of monoamine oxidase-A, and is therefore useful in the prophylaxis and treatment of certain mental disorders such as depression.
REFERENCES:
patent: 3310553 (1967-03-01), Bloom et al.
patent: 3642997 (1972-02-01), Shen et al.
patent: 4177257 (1979-12-01), Hodson et al.
D. Sheehan, J. Clin. Psychiatry 45:7, (1984), pp. 29-36.
Harfenist Morton
Joyner Charles T.
Brown Donald
Jiles Henry R.
Mullins J. G.
LandOfFree
Method for inhibiting monoamine oxidase-A and treating depressio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting monoamine oxidase-A and treating depressio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting monoamine oxidase-A and treating depressio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1617917